Dr. Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. Ginkgo is a synthetic biology company that genetically engineers "made-to-order" cells for customers in the chemical, pharmaceutical, food and energy industries. The company engineers these cells in their 100,000 sqft automated genetic engineering foundry and has partnerships with companies including ADM, Cargill and Ajinomoto as well as top five beverage, petrochemical and electronics companies. Ginkgo recently announced a $100M joint venture with Bayer to develop microbes to make food crops self-fertilizing and in 2017 Ginkgo was selected #7 on CNBC's Disruptor 50 List of fast-growing companies. Prior to Ginkgo, Jason received B.S. degrees in Chemical Engineering and Biology and a PhD in Biological Engineering all from MIT.